Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
776.75
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, May 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eli Lilly
< Previous
1
2
3
4
5
6
7
8
9
...
76
77
Next >
Costco Long Known For Rotisserie Chicken And Hot Dogs Counters Junk Food With Weight Loss Plan To Help You Shed Those Extras
April 03, 2024
Costco's new weight loss initiative, in partnership with Sesame, a healthcare marketplace, will offer members a three-month clinical consultation and other services for $179.
Via
Benzinga
5 Healthcare Stocks to Buy for 2024
April 02, 2024
Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
AstraZeneca CEO Highlights Decade-Long Sales Goal Of $45B Along With Investor Doubts As It Lags In Weight Loss Race
April 02, 2024
AstraZeneca's CEO Pascal Soriot celebrates hitting a $45 billion sales target set a decade ago despite initial skepticism. Investor confidence remains a challenge amid stagnant shares and concerns over...
Via
Benzinga
Citi Monitors Competitive Threats To Eli Lilly, Says It Is Positioned To Maintain Leadership And Expand
April 02, 2024
Citi Research raises price target for Eli Lilly, citing improved risk-adjusted sales outlook for GLP-1 agonist orforglipron. With Phase 3 trials ongoing since 2023, concerns about liver toxicity...
Via
Benzinga
What Analysts Are Saying About Eli Lilly and Co Stock
April 01, 2024
Via
Benzinga
Eli Lilly and Co's Options: A Look at What the Big Money is Thinking
March 27, 2024
Via
Benzinga
Gene Therapy Side Effects: Verve Therapeutics Halts Enrollment Of Lead Gene Therapy Trial In Patients With Bad Cholesterol
April 02, 2024
Verve Therapeutics' latest update on the Heart-1 Phase 1b trial of VERVE-101. Explore VERVE-102's development and regulatory clearances for the Heart-2 clinical trial, offering hope for patients with...
Via
Benzinga
Merger Mania: 3 Potential Takeover Targets to Watch for Lucrative Buyouts
April 02, 2024
With interest rates poised to fall, acquisitions will become more numerous. Here are three potential takeover targets.
Via
InvestorPlace
Eli Lilly Stock Navigates Weight-Loss Drug Competition With Technical Resilience
April 02, 2024
Eli Lilly's stock has performed well over the past year, gaining 116.84%. So far in 2024, the stock has returned 29.45% to investors.
Via
Benzinga
Meta Platforms, AMD Lead 10 Stocks Showing This Bullish Action
April 02, 2024
Several leading stocks are finding support around the 10-week line, creating potential buying opportunities.
Via
Investor's Business Daily
Buy Amazon Stock Now for Continued Growth and Diversification
April 02, 2024
Year to date, Amazon's share price is up 20%, nearly double the 11% gain in the benchmark S&P 500 index. Over the last 12 months, Amazon stock has gained 75%.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Could Viking Therapeutics Stock Be a Millionaire Maker?
April 02, 2024
There is a plausible path for this biotech stock to make some investors millionaires.
Via
The Motley Fool
Is It Too Late to Buy Eli Lilly Stock?
April 02, 2024
There's more to the Lilly story than just excellence in one treatment area.
Via
The Motley Fool
Top Stock Reports For Apple, Nvidia & Eli Lilly
April 01, 2024
Today's Research Daily features new research reports on 16 major stocks, including Apple Inc., NVIDIA Corporation, and Eli Lilly and Company.
Via
Talk Markets
Missed the "Magnificent Seven"? Try Buying These 3 Forever Stocks Instead
April 01, 2024
All three companies have very long runways for growth ahead.
Via
The Motley Fool
Meet The "Magnificent Seven" of Healthcare Stocks
April 01, 2024
The tech sector doesn't have a monopoly on magnificent corporations.
Via
The Motley Fool
2 Top Biotech Buyout Candidates
March 31, 2024
Investors who are adventurous, have a high-risk tolerance, and are home run hitters may opt for biotech stocks. Investors in this group may want to hone in on stocks that have the potential to be...
Via
Talk Markets
Have $1,500? 2 Top Growth Stocks to Buy Right Now for 2024 and Beyond
March 31, 2024
Great companies in steadily growing industries can deliver enviable returns through the years.
Via
The Motley Fool
3 Unstoppable Stocks to Buy Hand Over Fist in April
March 30, 2024
These stocks have exceptionally bright prospects.
Via
The Motley Fool
Biotech's Lawsuit With Eli Lilly Might Catalyze Stock
March 29, 2024
Nektar Therapeutics commenced a Phase 2b clinical trial evaluating its lead product candidate rezpegaldesleukin, in patients with severe to very severe alopecia areata, a disease-causing patchy hair...
Via
Talk Markets
Topics
Lawsuit
Exposures
Financial
Legal
The 3 Best Biotech Stocks to Buy in Q2 2024
March 29, 2024
Biotech can be a risky industry for investors, but we've done the legwork for you with these three biotech stocks for Q2.
Via
InvestorPlace
Bitcoin Vs. Gold Vs. SPY: Which Asset Class Would've Given Best Returns On $1000 Investment In Q1?
March 29, 2024
The first quarter of 2024 has turned out to be a blockbuster for most asset classes, and the strong performances have left investors worried about the sustainability of the uptrend.
Via
Benzinga
Stock Market Rally Shows Breadth As Leaders Take A Breath: Weekly Review
March 28, 2024
The stock market rally showed breadth, with small caps leading the way to a 24-month high. Growth leaders like Nvidia took a break.
Via
Investor's Business Daily
Here's How Much You Would Have Made Owning Eli Lilly and Co Stock In The Last 5 Years
March 28, 2024
Via
Benzinga
Eli Lilly vs. Berkshire Hathaway: Which Stock Will Become the Next Member of the $1 Trillion Club?
March 28, 2024
Don't assume that because Berkshire is worth nearly $900 billion, it's sure to get to $1 trillion first.
Via
The Motley Fool
Bull Market Buys: 3 Dividend Stocks to Own for the Long Run
March 28, 2024
Invest in stability, dividends, and growth with these three accomplished real estate operators.
Via
The Motley Fool
Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback
March 28, 2024
The FDA has delayed making a decision on Eli Lilly's donanemab, pending an advisory committee meeting.
Via
Investor's Business Daily
Exposures
Product Safety
Stock-Split Watch: Are These 2 Top Growth Stocks Next?
March 28, 2024
Shares of Eli Lilly and Regeneron are both well into the range where splits would make sense.
Via
The Motley Fool
Prediction: This Will Be the Next "Magnificent Seven" Stock
March 28, 2024
This particular company's growth is set to take off...
Via
The Motley Fool
US Companies In Japan Wary On Market Intervention As Yen Hits 34-Year Low Vs. Dollar
March 27, 2024
The Japanese yen fell Wednesday to a 34-year low against the dollar, which is a boon for exporters, but imports are more expensive.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
76
77
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.